Results 121 to 130 of about 17,808,763 (160)

Time Toxicity of Endocrine-based Oral CDK4/6 Inhibitor Therapies. [PDF]

open access: yesGeburtshilfe Frauenheilkd
Schäffler H   +17 more
europepmc   +1 more source

Real-world progression-free survival and overall survival in patients with HR<sup>+</sup>/HER2<sup>-</sup> advanced breast cancer treated in first-line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study. [PDF]

open access: yesInt J Cancer
Fasching PA   +20 more
europepmc   +1 more source

Corrigendum to "A Targeted Release Capsule of Lanthanum Carbonate: A New Efficient Cheap Treatment for Primary Hyperoxalurias" [Volume 10, Issue 2, February 2025, Pages 503-515]. [PDF]

open access: yesKidney Int Rep
De Broe ME   +8 more
europepmc   +1 more source

Ultra-Widefield Fluorescein Angiographic Quantitative Leakage Parameters and Clinical Outcomes in Nonproliferative Diabetic Retinopathy. [PDF]

open access: yesJAMA Ophthalmol
Ehlers JP   +9 more
europepmc   +1 more source

International Ski and Snowboard Federation (FIS) consensus statement on return-to-performance in competitive alpine and freestyle skiers and snowboarders. [PDF]

open access: yesBMJ Open Sport Exerc Med
Spörri J   +22 more
europepmc   +1 more source

Diabetic Retinopathy Severity on Ultra-Widefield Fluorescein Angiography versus Color Photography and Association with Risk of Disease Worsening. [PDF]

open access: yesOphthalmol Sci
Silva PS   +10 more
europepmc   +1 more source

Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. [PDF]

open access: yesJ Cancer Res Clin Oncol
Arndt V   +29 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy